Kosuke Hamai

Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis

Kosuke Hamai, Hiroshi Iwamoto, Nobuhisa Ishikawa et al. · Disease Markers · 2016 · 149 citations · Full text

Veterinary Medicine, Pathobiology, Pathology +15

Osimertinib versus osimertinib plus chemotherapy for non–small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial

Kentaro Tanaka, Hajime Asahina, Junji Kishimoto et al. · European Journal of Cancer · 2021 · 50 citations

Medicine, Oncology, Pharmacology +16

Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets

Yasushi Horimasu, Nobuhisa Ishikawa, Masaya Taniwaki et al. · BMC Medical Genetics · 2017 · 35 citations · Full text

Medicine, Molecular Biology, Pathology +17

Efficacy of mepolizumab in elderly patients with severe asthma and overlapping COPD in real-world settings: A retrospective observational study

Shoko Isoyama, Nobuhisa Ishikawa, Kosuke Hamai et al. · Respiratory Investigation · 2021 · 25 citations

Pharmacy, Internal Medicine, Pharmacotherapy +13

Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data

Yukari Tsubata, Keita Kawakado, Kosuke Hamai et al. · International Journal of Clinical Oncology · 2022 · 21 citations · Full text

Medicine, Biostatistics, Oncology +15